etoposide has been researched along with 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belcourt, MF; Cory, JG; Lin, ZP; Sartorelli, AC | 1 |
1 other study(ies) available for etoposide and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone
| Article | Year |
|---|---|
Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Colonic Neoplasms; Deoxyribonucleotides; DNA Damage; Down-Regulation; Doxorubicin; Enzyme Inhibitors; Etoposide; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Hydroxyurea; Intracellular Signaling Peptides and Proteins; Protein Subunits; Proto-Oncogene Proteins; Pyridines; Recombinant Proteins; Ribonucleotide Reductases; RNA, Small Interfering; Thiosemicarbazones; Tumor Suppressor Protein p53; Vincristine | 2004 |